Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

It’s Still Too Early to ‘Buy the Dip’ With Meta Platforms Stock

By Thomas Niel, InvestorPlace Contributor

'Watch and wait' remains your best move with META stock. Take a second look if shares encounter weakness in the coming months, but otherwise hold off buying.

7 Very Oversold Energy Stocks to Buy Right Now

By Thomas Niel, InvestorPlace Contributor

If worries about demand cease to outweigh tightening oil supplies, even these seven oversold energy stocks could soar.

Follow the Insiders and Sell QuantumScape Stock Now

By Thomas Niel, InvestorPlace Contributor

Follow the lead of QS stock insiders. Take some (or all) your chips off the table if you own it. If you do not own it, stay away.

7 Top Dividend Stocks for Income and Stability

By Thomas Niel, InvestorPlace Contributor

Strong fundamentals and long dividend growth track records make these the top seven dividend stocks to buy.

This F-Rated Cannabis Stock Is One of the Worst Companies You Could Buy Now

By Thomas Niel, InvestorPlace Contributor

Between uncertain prospects, dilution risk, and delisting risk, I'm clearly not exaggerating when I say ACB stock is not only one of the top cannabis stocks to sell, but one of the worst stocks overall.

Load More